157 related articles for article (PubMed ID: 22470196)
1. Stratification of Wilms tumor by genetic and epigenetic analysis.
Scott RH; Murray A; Baskcomb L; Turnbull C; Loveday C; Al-Saadi R; Williams R; Breatnach F; Gerrard M; Hale J; Kohler J; Lapunzina P; Levitt GA; Picton S; Pizer B; Ronghe MD; Traunecker H; Williams D; Kelsey A; Vujanic GM; Sebire NJ; Grundy P; Stiller CA; Pritchard-Jones K; Douglas J; Rahman N
Oncotarget; 2012 Mar; 3(3):327-35. PubMed ID: 22470196
[TBL] [Abstract][Full Text] [Related]
2. Deletion of WT1 and WIT1 genes and loss of heterozygosity on chromosome 11p in Wilms tumors in Japan.
Kaneko Y; Takeda O; Homma C; Maseki N; Miyoshi H; Tsunematsu Y; Williams BG; Saunders GF; Sakurai M
Jpn J Cancer Res; 1993 Jun; 84(6):616-24. PubMed ID: 8393432
[TBL] [Abstract][Full Text] [Related]
3. Molecular and epidemiologic characterization of Wilms tumor from Baghdad, Iraq.
Phelps HM; Al-Jadiry MF; Corbitt NM; Pierce JM; Li B; Wei Q; Flores RR; Correa H; Uccini S; Frangoul H; Alsaadawi AR; Al-Badri SAF; Al-Darraji AF; Al-Saeed RM; Al-Hadad SA; Lovvorn Iii HN
World J Pediatr; 2018 Dec; 14(6):585-593. PubMed ID: 30155617
[TBL] [Abstract][Full Text] [Related]
4. WT1-Mutant Wilms Tumor Progression Is Associated With Diverting Clonal Mutations of CTNNB1.
Duhme C; Busch M; Heine E; de Torres C; Mora J; Royer-Pokora B
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e180-e183. PubMed ID: 31876779
[TBL] [Abstract][Full Text] [Related]
5. Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children's Oncology Group AREN18B5-Q.
Murphy AJ; Cheng C; Williams J; Shaw TI; Pinto EM; Dieseldorff-Jones K; Brzezinski J; Renfro LA; Tornwall B; Huff V; Hong AL; Mullen EA; Crompton B; Dome JS; Fernandez CV; Geller JI; Ehrlich PF; Mulder H; Oak N; Maciezsek J; Jablonowski CM; Fleming AM; Pichavaram P; Morton CL; Easton J; Nichols KE; Clay MR; Santiago T; Zhang J; Yang J; Zambetti GP; Wang Z; Davidoff AM; Chen X
Nat Commun; 2023 Dec; 14(1):8006. PubMed ID: 38110397
[TBL] [Abstract][Full Text] [Related]
6. The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition: A Report from the Children's Oncology Group AREN18B5-Q Study.
Murphy AJ; Cheng C; Williams J; Shaw TI; Pinto EM; Dieseldorff-Jones K; Brzezinski J; Renfro LA; Tornwall B; Huff V; Hong AL; Mullen EA; Crompton B; Dome JS; Fernandez CV; Geller JI; Ehrlich PF; Mulder H; Oak N; Maciezsek J; Jablonowski C; Fleming AM; Pichavaram P; Morton CL; Easton J; Nichols KE; Clay MR; Santiago T; Zhang J; Yang J; Zambetti GP; Wang Z; Davidoff AM; Chen X
Res Sq; 2023 Mar; ():. PubMed ID: 36993649
[TBL] [Abstract][Full Text] [Related]
7. Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation.
Hu Q; Gao F; Tian W; Ruteshouser EC; Wang Y; Lazar A; Stewart J; Strong LC; Behringer RR; Huff V
J Clin Invest; 2011 Jan; 121(1):174-83. PubMed ID: 21123950
[TBL] [Abstract][Full Text] [Related]
8. Intra-Tumor Genetic Heterogeneity in Wilms Tumor: Clonal Evolution and Clinical Implications.
Cresswell GD; Apps JR; Chagtai T; Mifsud B; Bentley CC; Maschietto M; Popov SD; Weeks ME; Olsen ØE; Sebire NJ; Pritchard-Jones K; Luscombe NM; Williams RD; Mifsud W
EBioMedicine; 2016 Jul; 9():120-129. PubMed ID: 27333041
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy and terminal skeletal muscle differentiation in WT1-mutant Wilms tumors.
Royer-Pokora B; Beier M; Brandt A; Duhme C; Busch M; de Torres C; Royer HD; Mora J
Cancer Med; 2018 Apr; 7(4):1359-1368. PubMed ID: 29542868
[TBL] [Abstract][Full Text] [Related]
10. Gene expression studies of WT1 mutant Wilms tumor cell lines in the frame work of published kidney development data reveals their early kidney stem cell origin.
Royer-Pokora B; Wruck W; Adjaye J; Beier M
PLoS One; 2023; 18(1):e0270380. PubMed ID: 36689432
[TBL] [Abstract][Full Text] [Related]
11. Embryonal precursors of Wilms tumor.
Coorens THH; Treger TD; Al-Saadi R; Moore L; Tran MGB; Mitchell TJ; Tugnait S; Thevanesan C; Young MD; Oliver TRW; Oostveen M; Collord G; Tarpey PS; Cagan A; Hooks Y; Brougham M; Reynolds BC; Barone G; Anderson J; Jorgensen M; Burke GAA; Visser J; Nicholson JC; Smeulders N; Mushtaq I; Stewart GD; Campbell PJ; Wedge DC; Martincorena I; Rampling D; Hook L; Warren AY; Coleman N; Chowdhury T; Sebire N; Drost J; Saeb-Parsy K; Stratton MR; Straathof K; Pritchard-Jones K; Behjati S
Science; 2019 Dec; 366(6470):1247-1251. PubMed ID: 31806814
[TBL] [Abstract][Full Text] [Related]
12. Methylome analysis identifies a Wilms tumor epigenetic biomarker detectable in blood.
Charlton J; Williams RD; Weeks M; Sebire NJ; Popov S; Vujanic G; Mifsud W; Alcaide-German M; Butcher LM; Beck S; Pritchard-Jones K
Genome Biol; 2014 Aug; 15(8):434. PubMed ID: 25134821
[TBL] [Abstract][Full Text] [Related]
13. The genetic changes of Wilms tumour.
Treger TD; Chowdhury T; Pritchard-Jones K; Behjati S
Nat Rev Nephrol; 2019 Apr; 15(4):240-251. PubMed ID: 30705419
[TBL] [Abstract][Full Text] [Related]
14. Adult Wilms Tumor: Genetic Evidence of Origin of a Subset of Cases From Metanephric Adenoma.
Argani P; Tickoo SK; Matoso A; Pratilas CA; Mehra R; Tretiakova M; Sibony M; Meeker AK; Lin MT; Reuter VE; Epstein JI; Gagan J; Palsgrove DN
Am J Surg Pathol; 2022 Jul; 46(7):988-999. PubMed ID: 35184066
[TBL] [Abstract][Full Text] [Related]
15. The IGF signalling pathway in Wilms tumours--a report from the ENCCA Renal Tumours Biology-driven drug development workshop.
Maschietto M; Charlton J; Perotti D; Radice P; Geller JI; Pritchard-Jones K; Weeks M
Oncotarget; 2014 Sep; 5(18):8014-26. PubMed ID: 25478630
[TBL] [Abstract][Full Text] [Related]
16. Extrarenal Anaplastic Wilms Tumor: A Case Report With Genomic Analysis and Tumor Models.
Willis KR; Sathe AA; Xing C; Koduru P; Artunduaga M; Butler EB; Park JY; Kurmasheva RT; Houghton PJ; Chen KS; Rakheja D
J Pediatr Hematol Oncol; 2022 May; 44(4):147-154. PubMed ID: 35129140
[TBL] [Abstract][Full Text] [Related]
17. Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors.
Young MD; Mitchell TJ; Vieira Braga FA; Tran MGB; Stewart BJ; Ferdinand JR; Collord G; Botting RA; Popescu DM; Loudon KW; Vento-Tormo R; Stephenson E; Cagan A; Farndon SJ; Del Castillo Velasco-Herrera M; Guzzo C; Richoz N; Mamanova L; Aho T; Armitage JN; Riddick ACP; Mushtaq I; Farrell S; Rampling D; Nicholson J; Filby A; Burge J; Lisgo S; Maxwell PH; Lindsay S; Warren AY; Stewart GD; Sebire N; Coleman N; Haniffa M; Teichmann SA; Clatworthy M; Behjati S
Science; 2018 Aug; 361(6402):594-599. PubMed ID: 30093597
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors.
Wegert J; Ishaque N; Vardapour R; Geörg C; Gu Z; Bieg M; Ziegler B; Bausenwein S; Nourkami N; Ludwig N; Keller A; Grimm C; Kneitz S; Williams RD; Chagtai T; Pritchard-Jones K; van Sluis P; Volckmann R; Koster J; Versteeg R; Acha T; O'Sullivan MJ; Bode PK; Niggli F; Tytgat GA; van Tinteren H; van den Heuvel-Eibrink MM; Meese E; Vokuhl C; Leuschner I; Graf N; Eils R; Pfister SM; Kool M; Gessler M
Cancer Cell; 2015 Feb; 27(2):298-311. PubMed ID: 25670083
[TBL] [Abstract][Full Text] [Related]
19. TP53 mutational status is a potential marker for risk stratification in Wilms tumour with diffuse anaplasia.
Maschietto M; Williams RD; Chagtai T; Popov SD; Sebire NJ; Vujanic G; Perlman E; Anderson JR; Grundy P; Dome JS; Pritchard-Jones K
PLoS One; 2014; 9(10):e109924. PubMed ID: 25313908
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
